
Kimer Med
Operator of a biotech company intended for the development of novel, broad-spectrum antivirals. The company specializes in developing and testing and aims to bring to market broad-spectrum drugs for b...
Valuation
$27.4M
Latest known
Share Price
N/A
Total Raised
$11.5M
Last Round
N/A